Home
Class 14
GENERAL KNOWLEDGE
Name the company that has acquired an on...

Name the company that has acquired an online travel portal Yatra Online inc., for an enterprise value of $337.8 million, in an-all stock transactions.

A

Make my trip.com

B

Trivago

C

Ebix Inc

D

Trip Advisor

Text Solution

Verified by Experts

The correct Answer is:
C
Explanation: Ebix Inc has acquired an online travel portal yatra online Inc., for an enterprise value of $337.8 million, in an all-stock transaction. Ebix Inc. is a supplier of on-demand software and e-commerce service more focused on the Business to Business Segment whereas Yatra Online is more focused on the Business to Customer segment.
Promotional Banner

Topper's Solved these Questions

Similar Questions

Explore conceptually related problems

Growth through acquisitions and alliances has become a critical part of creating value for pharma and biotech manufacturers and their shareholders. However, companies and their investors may risk value destruction if they acquire rights to adrug that suddenly poses unanticipated safety risks for patients. Similarly, safety-related compliance violations committed by an acquired company could significantly impair the ultimate value of the transaction and the reputation of the acquire. The pace of deal-making between pharma and biotech companies continued to accelerate in 2006, increasing 17% to about $ 18 billion. Pharma companies were typically the buyers, and the premiums they paid increased substantially as competition intensified to secure access to novel drugs and biologics. The stakes increase everyday as competition pushes up prices and drives deal-making to earlier development stages with greater uncertainty and less time to complete thorough due diligence. Biotech companies are not capable of acquiring pharmaceutical companies.

Growth through acquisitions and alliances has become a critical part of creating value for pharma and biotech manufacturers and their shareholders. However, companies and their investors may risk value destruction if they acquire rights to adrug that suddenly poses unanticipated safety risks for patients. Similarly, safety-related compliance violations committed by an acquired company could significantly impair the ultimate value of the transaction and the reputation of the acquire. The pace of deal-making between pharma and biotech companies continued to accelerate in 2006, increasing 17% to about $ 18 billion. Pharma companies were typically the buyers, and the premiums they paid increased substantially as competition intensified to secure access to novel drugs and biologics. The stakes increase everyday as competition pushes up prices and drives deal-making to earlier development stages with greater uncertainty and less time to complete thorough due diligence. Pharmaceutical companies at times may incur loss after acquisition of biotech companies.

Growth through acquisitions and alliances has become a critical part of creating value for pharma and biotech manufacturers and their shareholders. However, companies and their investors may risk value destruction if they acquire rights to adrug that suddenly poses unanticipated safety risks for patients. Similarly, safety-related compliance violations committed by an acquired company could significantly impair the ultimate value of the transaction and the reputation of the acquire. The pace of deal-making between pharma and biotech companies continued to accelerate in 2006, increasing 17% to about $ 18 billion. Pharma companies were typically the buyers, and the premiums they paid increased substantially as competition intensified to secure access to novel drugs and biologics. The stakes increase everyday as competition pushes up prices and drives deal-making to earlier development stages with greater uncertainty and less time to complete thorough due diligence. Acquisitions of biotech companies was preferred among pharmaceutical companies in the recent past.

Growth through acquisitions and alliances has become a critical part of creating value for pharma and biotech manufacturers and their shareholders. However, companies and their investors may risk value destruction if they acquire rights to adrug that suddenly poses unanticipated safety risks for patients. Similarly, safety-related compliance violations committed by an acquired company could significantly impair the ultimate value of the transaction and the reputation of the acquire. The pace of deal-making between pharma and biotech companies continued to accelerate in 2006, increasing 17% to about $ 18 billion. Pharma companies were typically the buyers, and the premiums they paid increased substantially as competition intensified to secure access to novel drugs and biologics. The stakes increase everyday as competition pushes up prices and drives deal-making to earlier development stages with greater uncertainty and less time to complete thorough due diligence. Safety-related issues are prime concerns for the pharmaceutical companies while negotiating acquisition of biotech companies.

Growth through acquisitions and alliances has become a critical part of creating value for pharma and biotech manufacturers and their shareholders. However, companies and their investors may risk value destruction if they acquire rights to adrug that suddenly poses unanticipated safety risks for patients. Similarly, safety-related compliance violations committed by an acquired company could significantly impair the ultimate value of the transaction and the reputation of the acquire. The pace of deal-making between pharma and biotech companies continued to accelerate in 2006, increasing 17% to about $ 18 billion. Pharma companies were typically the buyers, and the premiums they paid increased substantially as competition intensified to secure access to novel drugs and biologics. The stakes increase everyday as competition pushes up prices and drives deal-making to earlier development stages with greater uncertainty and less time to complete thorough due diligence. Stiff competitions among the prospective buyers have resulted into erosion of value of the biotech companies.

PINNACLE-CURRENT AFFAIRS-Miscellaneous.
  1. As of January 2020, which of the following countries had NOT independe...

    Text Solution

    |

  2. In April 2019, scientists in produced the world's first 3D printed he...

    Text Solution

    |

  3. Name the company that has acquired an online travel portal Yatra Onlin...

    Text Solution

    |

  4. Irianin Major General Qasim Soleimani was recently (2020) assassinated...

    Text Solution

    |

  5. As per the government rules, how much percentage of advance tax needs ...

    Text Solution

    |

  6. VISHWAS, which is a major e-governance initiative launched by the gove...

    Text Solution

    |

  7. The researchers of which academic institution employed the nanoscale p...

    Text Solution

    |

  8. Which is the first Indian company to hit the ₹10 lakh crore mark in ma...

    Text Solution

    |

  9. The Indian Railways has integrated its helpline numbers into a single ...

    Text Solution

    |

  10. The Indian Army is set to commission the first batch of women soldiers...

    Text Solution

    |

  11. The ‘Hyderabad Fund’ had been held by the in the account of the High ...

    Text Solution

    |

  12. The excavated remains of found near Patna in Bihar was inscribed as a...

    Text Solution

    |

  13. Which of the following companies has roped in cricketer Harbhajan Sing...

    Text Solution

    |

  14. The International Naval event 'Milan' is scheduled to be held in in M...

    Text Solution

    |

  15. According to data available as of 2019, how many national parks are si...

    Text Solution

    |

  16. UN Women propose to partner with gender park with an aim to secure ge...

    Text Solution

    |

  17. In July 2019, which among the following operations was launched by the...

    Text Solution

    |

  18. W hich of the following regions has earned Geographical Indication for...

    Text Solution

    |

  19. India holds theposition in the production of cows’ milk as of January ...

    Text Solution

    |

  20. In January 2020, with which country did India sign a MoU for a content...

    Text Solution

    |